In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.
about
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line.Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment.Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells.Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL.EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus.
P2860
Q33297034-C2D4DF1F-F4AE-4077-8179-E638CC54DD15Q33673610-6C1E4447-7916-4B8E-AD0D-4CA7F1651768Q34576340-7E304C97-28D8-4AD1-8718-5319FD99FD78Q34658852-1066F980-FBD9-476B-8C7A-0BEE55591754Q35242466-FB696D02-84C2-4DFB-AC6B-734B7DC06687Q36713194-29FC0114-4321-4C71-B262-8DB8FD1B9169Q37550182-9BE92A0E-FBB8-4FCD-8E1F-88DC4AB50E73Q37901020-D47D73AB-8F82-4AD9-B03C-9138B7374090Q38706339-D47F0173-3438-4FDD-B94C-6853D9EFC635Q39558930-B304FF21-D5AA-4B2C-955F-D3677948B1C9Q40126382-389F0F9E-21EC-44FA-9C82-ABE38B79A4E0Q43225878-96AD57BF-C27C-4D97-A431-D092927C3AC4Q45428861-24208FE4-AC5D-4524-8B62-26C6422C52BF
P2860
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
In vitro EBV-infected subline ...... 4 induce LMP-1 but not EBNA-2.
@en
type
label
In vitro EBV-infected subline ...... 4 induce LMP-1 but not EBNA-2.
@en
prefLabel
In vitro EBV-infected subline ...... 4 induce LMP-1 but not EBNA-2.
@en
P2093
P356
P1476
In vitro EBV-infected subline ...... 4 induce LMP-1 but not EBNA-2.
@en
P2093
Ann Ohlsson
George Klein
Jun Nishikawa
Kenzo Takada
Loránd L Kis
Miki Takahara
Noémi Nagy
P Göran Elmberger
P304
P356
10.1002/IJC.20654
P577
2005-03-01T00:00:00Z